Bumrungrad Hospital Public Company Limited (SET: BH) has announced its 3Q23 consolidated financial statement through the Stock Exchange of Thailand as follows;
| Quarter | 3Q23 | 3Q22 |
| Net Profit (Loss) Million Baht |
1,954.43 | 1,501.34 |
| Earning Per Share (Baht) |
2.4600 | 1.8900 |
| % Change | 30.18 | |
| 9 Months | 2023 | 2022 |
| Net Profit (Loss) Million Baht |
5,285.62 | 3,392.33 |
| Earning Per Share (Baht) | 6.6500 | 4.2700 |
| % Change | 55.81 | |
BH reported total revenues in 3Q23 of Baht 6,775 million, an 18.0% increase from Baht 5,740 million in 3Q22. Net profit for 3Q23 increased by 30.2% to Baht 1,954 million from Baht 1,501 million in 3Q22, with net profit margin at 28.8% in 3Q23, compared to 26.2% in 3Q22.
BH reported revenues from hospital operations of Baht 6,720 million in 3Q23, a 18.5% increase year-over-year from Baht 5,673 million in 3Q22. This was mostly due to an increase in revenues from Thai and non-Thai patients by 20.2% and 17.6%, respectively. As a result, the revenue contribution from Thai patients was 33.1%, whereas revenue from non-Thai patients was 66.9% for 3Q23 compared with 32.6% and 67.4%, respectively, for 3Q22.
When compared with 3Q19, in order to gauge the performance of the current quarter to pre-covid levels, 3Q23 total revenues and net profit increased by 42.4% and 85.2%, respectively, from 3Q19. Net profit margin rose to 28.8% in 3Q23, compared to 22.2% in 3Q19.
